StonvexLoading…
StonvexCore line items from HESM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $388.70M | $1.62B | $1.21B | $794.50M |
Operating Income | $238.10M | $1.01B | $756.50M | $497.60M |
Net Income | $87.60M | $352.90M | $259.60M | $161.90M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $4.32B | $4.39B | $4.44B | $4.42B |
Total Liabilities | $3.94B | $3.95B | $4.01B | $3.92B |
Cash & Equivalents | $4.60M | $1.90M | $5.50M | $4.50M |
Free Cash Flow OCF − CapEx | $224.50M | $728.20M | $549.30M | $370.40M |
Shares Outstanding | Not available | Not available | Not available | Not available |